A Twelve-Month, Open Label, Multicenter Study to Evaluate the Safety of a 1.3 g Oral Dose of a New Modified-Release Tranexamic Acid Formulation Administered Three Times Daily as Needed for up to 5 Days During the

  • Muse, Kenneth (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/0512/31/08